Latest AI and machine learning research in other cancers for healthcare professionals.
BACKGROUND: Early detection and management are essential in hepatocellular carcinoma (HCC) care. Artificial intelligence (AI) is enhancing the precision and efficiency of diagnostic imaging for liver tumor assessment. OBJECTIVE: This study aimed to characterize the diagnostic performance of AI algorithms for detecting HCC via systematic review and meta-analysis. METHODS: A systematic literature se...
Artificial intelligence (AI)-based decision support systems are increasingly explored in surgical oncology. However, their concordance with multidisciplinary tumor board (MTB) decisions, particularly in complex gastrointestinal malignancies, remains insufficiently characterized. This retrospective observational study included 47 patients who underwent oncological surgery and were discussed at a mu...
BACKGROUND: ∼60%-70% of patients with metastatic non-small cell lung cancer (NSCLC) have relatively low tumor mutational burden (TMB), with limited bi...
Prostate-specific membrane antigen (PSMA) PET/CT is routinely used to restage prostate cancer (PCa) in patients with biochemical recurrence (BCR), yet...
Cancer is characterized by extensive genetic variability, continuous evolutionary change, and intricate interactions with its surrounding microenviron...
Hepatocellular carcinoma (HCC) treatment faces significant challenges, particularly in tumor growth, metastasis, and drug resistance. While several pr...
Endoscopic retrograde cholangiopancreatography (ERCP)-based tissue acquisition is the cornerstone for assessment of suspected malignant biliary strict...
Although significant progress has been achieved in diagnosing papillary thyroid carcinoma (PTC), it remains a challenge to diagnose thyroid nodules (T...
OBJECTIVE: Dysregulation of Protein post-translation(PTM) and Treg/Th17 balance contribute to the progression of Hepatocellular Carcinoma(HCC) patient...
BACKGROUND: Aspartame (APM), a widely used sweetener, has been linked to cancers, yet its molecular impact on metabolic dysfunction-associated steatot...
Colorectal cancer (CC) arises from a complex interplay between genetic and epigenetic alterations within the colorectal mucosa, resulting in unchecked...
BACKGROUND: Non-small cell lung cancer (NSCLC) accounts for approximately 85% of primary pulmonary neoplasms. Complete surgical removal remains the co...
BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is an aggressive tumor with high metastatic potential and therapeutic resistance, yet the role of ...
Endometrial cancer (EC) is the most common gynaecological malignancy worldwide, yet the prognosis for advanced and recurrent disease remains poor, hig...
BACKGROUND: Palliative care improves the quality of life of people living with life-limiting conditions and their families; however, global access rem...
OBJECTIVES: This study aimed to use machine learning to explore Behçet's syndrome (BS) heterogeneity by integrating immunocyte subpopulations and clin...
Cervical, endometrial, ovarian, vulvar, vaginal, fallopian tube, and gestational trophoblastic neoplasia (GTN) are major gynecologic cancers that sign...
Malignant tumors, including osteosarcoma (OS), are major non-communicable chronic diseases driven by systemic inflammation and oxidative stress. While...
Tumor heterogeneity-encompassing diverse cellular phenotypes, genomic alterations, and micro-environmental contexts-is a principal barrier to effectiv...
RATIONALE AND OBJECTIVE: Anaplastic thyroid carcinoma (ATC) may arise from the progression of differentiated thyroid cancers, but the mechanisms are n...